There is no TGA-registered BPC-157 product for therapeutic use in Australia, and as of June 2024 BPC-157 is a Schedule 4 (prescription-only) substance, meaning any legal supply must come through a doctors prescription via a compounding pharmacy
Predictions by Model II agree well with the size-resolved CCN measurements, while predictions by Model I overestimate the critical supersaturation values
Have bought many products and will continue to do so
What Gets Evaluated Skin type and tone: Fitzpatrick scale assessment to determine baseline melanin levels and realistic outcome range Cause of pigmentation: Is it hormonal, sun-damage related, post-inflammatory, or genetic
Nutrition: Keep protein intake adequate and overall diet balanced to support metabolism and lean mass
Ethics declarations Conflict of Interest The authors have no conflicts of interest to disclose